Analyst Coverage

Tilray Medical launches sleep-oriented CBN Night Oil for medical cannabis patients in Canada

Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use. Blair MacNeil, President, Tilray Canada,…

Canada’s big banks see positive outlook while cannabis growers struggle with latest earnings. Here are the past week’s winners and losers

The bank always wins, and last week was no exception. Among the many quarterly earnings released by Canada’s major financial institutions, Scotiabank’s stood out for a 12 per cent profit increase compared with those in the same quarter a year earlier. Analysts found a bright spot in Scotiabank’s commercial lending programs, where loan balances grew 19 per cent in the…

B.C. cannabis company loses bid to suppress disaffected shareholder

Emerald Health Sciences sought an injunction against a shareholder who raised concerns about company ties to a major U.S. fraud investigation. A B.C. cannabis company has lost a court case against a disaffected shareholder, who claims he was “oppressed” to remain quiet about the firm’s connections to a major securities fraud scheme alleged in the United States. Emerald Health Sciences…

A cannabis store in every strip mall might be too much for Alberta

Cannabis Benchmarks analysis suggests Alberta has more than ‘optimal’ number From behind the counter of a northwest Calgary cannabis shop, Alex Macyszyn serves a handful of midday customers.  He has plenty of company in his line of work: there are at least three other cannabis stores within a five-minute drive, and another one that recently closed down.  “There’s way too…

Industry lobby group to focus on taxation, regulation changes in Ottawa meet-and-greet

Canada’s cannabis industry has a tax problem.  While the industry may have been happy to accept an onerous excise tax regime in exchange for Canada’s legalizing recreational cannabis sales back in 2018, fast forward to today and those fees have become an anchor that has dragged down the country’s producers, both large and small, which have struggled to become profitable.…